Intranasal application of a bifunctional pertactin-RTX fusion antigen elicits protection of mouse airway mucosa against Bordetella pertussis colonization

Intranasal application of a bifunctional pertactin-RTX fusion antigen elicits protection of mouse airway mucosa against Bordetella pertussis colonization

ABSTRACT The adenylate cyclase toxin (ACT, AC-Hly, or CyaA) plays a key role in airway infections by Bordetella pertussis and ablates the oxidative burst and opsonophagocytic capacity of sentinel phagocytes. CyaA fragments eliciting toxin-neutralizing antibodies are considered prime antigen candidat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Carlos Espinosa-Vinals, Jana Holubova, Ondrej Stanek, Radim Osicka, Jiri Masin, Fresia Esther Arellano Herencia, Peter Sebo
Format:	Article
Language:	English
Published:	American Society for Microbiology 2025-04-01
Series:	mSphere
Subjects:	Bordetella pertussis adenylate cyclase toxin pertactin whooping cough pertussis protein folding
Online Access:	https://journals.asm.org/doi/10.1128/msphere.00959-24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pertactin deficiency of Bordetella pertussis: Insights into epidemiology, and perspectives on surveillance and public health impact
by: Ulrich Heininger, et al.
Published: (2024-12-01)

Prevalence of Pertactin-Deficient Bordetella pertussis Isolates, Slovenia
by: Alex-Mikael Barkoff, et al.
Published: (2024-11-01)

Nuanced differences in adenylate cyclase toxin production, acylation, and secretion may contribute to the evolution of virulence in Bordetella species
by: Alexa R. Wolber, et al.
Published: (2025-06-01)

Less reactogenic whole-cell pertussis vaccine confers protection from Bordetella pertussis infection
by: Karolína Škopová, et al.
Published: (2025-04-01)

Bordetella pertussis diagnosis in children under five years of age in the Regional Hospital of Cajamarca, Northern Peru
by: Juana del Valle-Mendoza, et al.
Published: (2015-11-01)

Mucosal IgA Antibodies are Critical for Bacterial Clearance of Bordetella pertussis in the Baboon Model
by: Gaurav Chauhan, et al.
Published: (2025-06-01)

Incidence and severity of pertussis among hospitalized infants, Sarawak, Malaysia, 2015-2021
by: Anand Mohan, et al.
Published: (2024-09-01)

FEATURES OF GENOTYPiNG VARIABILITY OF STRAINS OF BORDETELLA PERTUSSIS ALLOCATED FROM PATIENTS WITH WHOOPING COUGH IN RUSSIA
by: V. A. Aleshkin, et al.
Published: (2012-09-01)

Do not let perfect be the enemy of good: the current reality of Bordetella testing
by: Rebecca Yee
Published: (2025-01-01)

Pertussis vaccination in adults: a behavioral study of physicians from the US, France, and Germany
by: Donald Middleton, et al.
Published: (2024-11-01)

As pertussis returns to pre-COVID19 endemicity, vaccination remains our best ally against an evolving Bordetella pertussis
by: Zeng Mei, et al.
Published: (2025-12-01)

Humoral immunity to adhesins and toxins of the pertussis pathogen in mice immunized with experimental acellular pertussis vaccines from biofilm and planktonic cultures of <i>Bordetella pertussis</i>
by: Evgeny M. Zaitsev, et al.
Published: (2025-05-01)

SUSCEPTIBILITY OF BORDETELLA PERTUSSIS STRAINS TO ANTIBACTERIAL PREPARATIONS
by: O. Yu. Borisova, et al.
Published: (2015-08-01)

Comparison of the clinical and laboratory characteristics of pertussis or viral lower respiratory tract infections
by: Suna Selbuz, et al.
Published: (2019-09-01)

Clinical characteristics of pertussis in infants and risk factors for respiratory support
by: Cui Liru, et al.
Published: (2025-12-01)

Pertussis — An update for general practice
by: A. Madide, et al.
Published: (2006-05-01)

Structure of Population of Strains of the Bordetella pertussis in the Russia
by: O. Yu. Borisova, et al.
Published: (2016-08-01)

In vivo RNA-seq and infection model reveal the different infection and immune characteristics of B. pertussis strains in China
by: Weilun Zuo, et al.
Published: (2025-06-01)

The 2024 resurgence of Bordetella pertussis in Brazil and a decade-long epidemiological overview
by: Nathália Mariana Santos Sansone, et al.
Published: (2025-05-01)

Seroepidemiological Assessment of Bordetella pertussis in Jahrom, Southern Iran: A Cross‐Sectional Study
by: Rahim Raufi, et al.
Published: (2025-02-01)

Immunization status of Iranian military recruits against Bordetella pertussis infection (whooping cough)
by: Morteza Izadi, et al.
Published: (2011-03-01)

Highlights of the 14th International Bordetella Symposium
by: Kevin Munoz Navarrete, et al.
Published: (2025-06-01)

Resurgence of pertussis: Epidemiological trends, contributing factors, challenges, and recommendations for vaccination and surveillance
by: Sijia Wang, et al.
Published: (2025-12-01)

Vaccine antigen-based genotyping of Bordetella pertussis by direct Sanger sequencing of clinical samples in Peru from 2018 to 2019
by: Eduardo Juscamayta-López, et al.
Published: (2025-06-01)

Impact of nutrient medium composition on protein profiling of Bordetella spp.
by: Vidmanova M.V., et al.
Published: (2024-12-01)

Protective Activity and Safety of Acellular Pertussis Vaccine from Vaccine and Freshly Isolated Strain Bordetella pertussis
by: E. M. Zaitsev, et al.
Published: (2017-04-01)

The incidence and clinical effects of Bordetella pertussis in children hospitalized with acute bronchiolitis
by: Emilya Efendiyeva, et al.
Published: (2020-10-01)

A highly conserved sRNA downregulates multiple genes, including a σ54 transcriptional activator, in the virulence mode of Bordetella pertussis
by: Minji Sim, et al.
Published: (2025-08-01)

Bordetella adenylate cyclase toxin elicits chromatin remodeling and transcriptional reprogramming that blocks differentiation of monocytes into macrophages
by: Jawid Nazir Ahmad, et al.
Published: (2025-04-01)

Clinical and Epidemiological Characteristics of Pediatric Pertussis Cases: A Retrospective Study from Southeast Romania
by: Cristina Maria Mihai, et al.
Published: (2025-04-01)

Role of Peripheral Blood Smear in Rapid and Confirmative Pertussis Diagnosis: A Case Report
by: Omar Alswailmi, et al.
Published: (2024-01-01)

Exploiting subtractive genomics to identify novel drug targets and new immunogenic candidates against Bordetella pertussis: an in silico study
by: Mahshid Khazani Asforooshani, et al.
Published: (2025-05-01)

Population dynamics and antigenic drift of Bordetella pertussis following whole cell vaccine replacement, Barcelona, Spain, 1986–2015
by: Alba Mir-Cros, et al.
Published: (2019-01-01)

Immunogenicity of GamLPV, an intranasal live vaccine for pertussis prevention, in adult volunteers: a blind, randomised, placebo-controlled trial to optimise the method and schedule of administration
by: A. A. Lidzhieva, et al.
Published: (2025-04-01)

The evolution of Bordetella pertussis has selected for mutations of acr that lead to sensitivity to hydrophobic molecules and fatty acids
by: Iain MacArthur, et al.
Published: (2019-01-01)

Immunization with whole cell but not acellular pertussis vaccines primes CD4 TRM cells that sustain protective immunity against nasal colonization with Bordetella pertussis
by: Mieszko M. Wilk, et al.
Published: (2019-01-01)

Genomic epidemiology and evolution of Bordetella pertussis under the vaccination pressure of acellular vaccines in Beijing, China, 2020–2023
by: Zhen Li, et al.
Published: (2025-12-01)

Antimicrobial Susceptibility Testing to Erythromycin and Azithromycin of Clinical Isolates of Bordetella pertussis Circulating in Russia
by: A. S. Pimenova, et al.
Published: (2024-07-01)

Molecular epidemiology and genomic features of Bordetella pertussis in Tianjin, China, 2023
by: Xiaohui Lu, et al.
Published: (2025-08-01)

Immunobiological Properties of Biofilms of Bacteria of the Genus Bordetella
by: E. M. Zaitsev, et al.
Published: (2021-11-01)